Brevard County is seeing increased investment in medical research, with local institutions expanding clinical trials focused on age-related conditions. As of May 2026, the county hosts three major research facilities conducting studies on cardiovascular disease, diabetes, and neurodegenerative disorders. These efforts align with Florida's status as the nation's third-fastest growing state, where 22% of residents are over 65. "We're seeing more partnerships between hospitals and universities," said Dr. Lena Torres, director of the Brevard Medical Innovation Center. "The demand for clinical trials has grown 40% since 2020." The University of Central Florida's Brevard campus recently launched a $35 million expansion to its biotechnology lab, which will support trials for cancer treatments and mobility aids. Meanwhile, the Florida Institute for Health Innovation has partnered with local hospitals to recruit 1,200 new participants for ongoing studies. This growth is fueled by Brevard's unique demographics: 18% of residents are seniors, compared to the state average of 16%. The county's healthcare network reported a 35% increase in patients with chronic conditions between 2021 and 2025. Industry experts note that the rise in telemedicine and digital health tools has made it easier to conduct trials across the county's 12 hospitals and 50 clinics. However, researchers face challenges in securing enough volunteers for trials, particularly in rural areas of the county. Local officials are working with the Florida Department of Health to launch outreach programs targeting underserved communities. The state's overall medical research budget has grown to $2.1 billion annually, with Brevard's share increasing from 8% in 2020 to 12% in 2026. This expansion has created new job opportunities, with 450 medical research positions added in Brevard since 2022. The county's economic development office reports that medical tech startups have increased by 60% over the past five years, with several focusing on wearable health devices and AI diagnostics. As the population continues to grow, local leaders say the focus will remain on making clinical trials more accessible to all residents.